Neuraxis logo

Neuraxis share price today

(NRXS)

Neuraxis share price is $2.7 & ₹231.69 as on 7 Jan 2025, 2.30 'hrs' IST

$2.7

0.28

(11.57%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Neuraxis share price in Dollar and Rupees. Guide to invest in Neuraxis stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Neuraxis, along with analyst recommendations, forecasts, and comprehensive financials.

Neuraxis share price movements

  • Today's Low: $2.49
    Today's High: $2.70

    Day's Volatility :7.77%

  • 52 Weeks Low: $2.00
    52 Weeks High: $3.89

    52 Weeks Volatility :48.58%

Neuraxis Returns

PeriodNeuraxis IncIndex (Russel 2000)
3 Months
-20.39%
0.0%
6 Months
-13.57%
0.0%
1 Year
-10.7%
0.0%
3 Years
-59.67%
-19.8%

Neuraxis Key Statistics

in dollars & INR

Previous Close
$2.42
Open
$2.7
Today's High
$2.7
Today's Low
$2.4901
Market Capitalization
$16.4M
Today's Volume
$29.0K
52 Week High
$3.89
52 Week Low
$2.0001
Revenue TTM
$2.3M
EBITDA
$-8.6M
Earnings Per Share (EPS)
$-0.4
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

How to invest in Neuraxis from India?

It is very easy for Indian residents to invest directly in Neuraxis from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Neuraxis stock in both Indian Rupees (INR) and US Dollars (USD). Search for Neuraxis or NRXS on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Neuraxis or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Neuraxis shares which would translate to 0.318 fractional shares of Neuraxis as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Neuraxis, in just a few clicks!

Returns in Neuraxis for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Neuraxis investment value today

Current value as on today

₹1,02,854

Returns

₹2,854

(+2.85%)

Returns from Neuraxis Stock

₹369 (-0.37%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Neuraxis

-8%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Neuraxis on INDmoney from India has reduced in the last 30 days as on Jan 7, 2025. -8% less investors are searching Neuraxis in the last 30 days versus the previous period.

Analyst Recommendation on Neuraxis

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Neuraxis(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Neuraxis

What analysts predicted

Upside of 177.78%

Current:

$2.70

Target:

$7.50

Insights on Neuraxis

  • Price Movement

    In the last 1 month, NRXS stock has moved down by -10.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 611.5K → 666.62K (in $), with an average increase of 8.3% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -2.91M → -1.75M (in $), with an average increase of 66.2% per quarter
  • NRXS vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 23.7% return, outperforming this stock by 27.3%
  • Price to Sales

    ForNRXS every $1 of sales, investors are willing to pay $6.1, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Neuraxis Financials in INR & Dollars

FY20Y/Y Change
Revenue
$1.9M
-
Net Income
$-4.1M
-
Net Profit Margin
-209.83%
-
FY21Y/Y Change
Revenue
$2.7M
↑ 40.98%
Net Income
$-3.1M
↓ 24.12%
Net Profit Margin
-112.93%
↑ 96.9%
FY22Y/Y Change
Revenue
$2.7M
↓ 1.34%
Net Income
$-4.8M
↑ 55.54%
Net Profit Margin
-178.05%
↓ 65.12%
FY23Y/Y Change
Revenue
$2.5M
↓ 8.37%
Net Income
$-14.6M
↑ 205.99%
Net Profit Margin
-594.57%
↓ 416.52%
Q2 FY23Q/Q Change
Revenue
$646.0K
↓ 19.76%
Net Income
$-2.2M
↑ 2.86%
Net Profit Margin
-346.06%
↓ 76.11%
Q3 FY23Q/Q Change
Revenue
$477.5K
↓ 26.09%
Net Income
$-4.9M
↑ 119.37%
Net Profit Margin
-1.0K%
↓ 681.12%
Q4 FY23Q/Q Change
Revenue
$531.5K
↑ 11.31%
Net Income
$-5.3M
↑ 8.34%
Net Profit Margin
-999.76%
↑ 27.42%
Q1 FY24Q/Q Change
Revenue
$646.6K
↑ 21.67%
Net Income
$-2.1M
↓ 60.09%
Net Profit Margin
-327.95%
↑ 671.81%
Q2 FY24Q/Q Change
Revenue
$611.5K
↓ 5.43%
Net Income
$-2.9M
↑ 37.59%
Net Profit Margin
-477.14%
↓ 149.19%
Q3 FY24Q/Q Change
Revenue
$666.6K
↑ 9.01%
Net Income
$-1.8M
↓ 39.84%
Net Profit Margin
-263.3%
↑ 213.84%
FY20Y/Y Change
Profit
$1.4M
-
FY21Y/Y Change
Profit
$2.3M
↑ 55.52%
FY22Y/Y Change
Profit
$2.4M
↑ 5.95%
FY23Y/Y Change
Profit
$2.2M
↓ 9.67%
Q2 FY23Q/Q Change
Profit
$578.2K
↓ 18.47%
Q3 FY23Q/Q Change
Profit
$410.2K
↓ 29.06%
Q4 FY23Q/Q Change
Profit
$459.1K
↑ 11.93%
Q1 FY24Q/Q Change
Profit
$571.6K
↑ 24.49%
Q2 FY24Q/Q Change
Profit
$538.0K
↓ 5.86%
Q3 FY24Q/Q Change
Profit
$569.6K
↑ 5.86%
FY20Y/Y Change
Operating Cash Flow
$-4.1M
-
Investing Cash Flow
$-27.7K
-
Financing Cash Flow
$6.1M
-
FY21Y/Y Change
Operating Cash Flow
$-2.2M
↓ 46.02%
Investing Cash Flow
$-1.4K
↓ 94.99%
Financing Cash Flow
$661.1K
↓ 89.08%
Q2 FY23Q/Q Change
Operating Cash Flow
$-625.2K
↑ 0.37%
Investing Cash Flow
$-5.5K
↓ 28.25%
Financing Cash Flow
$636.7K
↑ 50.77%

Neuraxis Technicals Summary

Sell

Neutral

Buy

Neuraxis is currently in a neutral trading position according to technical analysis indicators.

Neuraxis Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Neuraxis Inc
-17.69%
-13.57%
-10.7%
-59.67%
-59.67%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Neuraxis Inc
NA
NA
NA
0.0
0.0
-2.6
NA
-0.22
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Neuraxis Inc
Buy
$16.4M
-59.67%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Neuraxis

Organization
Neuraxis
Employees
19
CEO
Mr. Brian Carrico
Industry
Miscellaneous

Management People of Neuraxis

NameTitle
Mr. Brian Carrico
President, CEO & Director
Mr. Timothy Robert Henrichs
Chief Financial Officer
Dr. Adrian Miranda
Senior VP of Science & Technology and Chief Medical Officer
Dr. Thomas Carrico
Chief Regulatory Officer and Compliance & Privacy Officer
Dr. Christopher Robin Brown D.D.S.
Founder, Director of Innovation & Director

Important FAQs about investing in Neuraxis from India :

What is Neuraxis share price today?

Neuraxis share price today stands at $2.70, Open: $2.70 ; Previous Close: $2.42 ; High: $2.70 ; Low: $2.49 ; 52 Week High: $3.89 ; 52 Week Low: $2.00. The stock opens at $2.70, after a previous close of $2.42. The stock reached a daily high of $2.70 and a low of $2.49, with a 52-week high of $3.89 and a 52-week low of $2.00.

Can Indians buy Neuraxis shares?

Yes, Indians can invest in the Neuraxis (NRXS) from India.

With INDmoney, you can buy Neuraxis at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Neuraxis at zero transaction cost.

How can I buy Neuraxis shares from India?

It is very easy to buy Neuraxis from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Neuraxis be purchased?

Yes, you can buy fractional shares of Neuraxis with INDmoney app.

What are the documents required to start investing in Neuraxis stocks?

To start investing in Neuraxis, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Neuraxis

Today’s highest price of Neuraxis (NRXS) is $2.70.

Today’s lowest price of Neuraxis (NRXS) is $2.49.

What is today's market capitalisation of Neuraxis

Today's market capitalisation of Neuraxis NRXS is 16.4M

What is the 52 Week High and Low Range of Neuraxis

  • 52 Week High

    $3.89

  • 52 Week Low

    $2.00

What are the historical returns of Neuraxis?

  • 1 Month Returns

    -17.69%

  • 3 Months Returns

    -13.57%

  • 1 Year Returns

    -10.7%

  • 5 Years Returns

    -59.67%

Who is the Chief Executive Officer (CEO) of Neuraxis

Mr. Brian Carrico is the current Chief Executive Officer (CEO) of Neuraxis.